Related Experiment Video
Updated: Jan 18, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Dynamic of Pediatric Invasive Bacterial Infections in Switzerland: A 2017-2024 Time-series Analysis of National Data
Manon Jaboyedoff1, Anita Niederer-Loher2, Christian R Kahlert2
1From the Department Women-Mother-Child, Unit of Pediatric Infectious Diseases and Vaccinology, Service of Pediatrics, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
Insights
Vaccine-preventable invasive bacterial infections (IBIs) in children were less impacted by COVID-19 public health measures than invasive group A streptococcal infections. This highlights differing bacterial pathogen responses to interventions.
Area of Science:
- Pediatric infectious diseases
- Epidemiology
- Public health interventions
Background:
- The coronavirus disease 2019 (COVID-19) pandemic prompted widespread nonpharmaceutical interventions (NPIs).
- The impact of these NPIs on various bacterial infections, particularly in pediatric populations, remains incompletely understood.
- Invasive bacterial infections (IBIs) represent a significant global health concern in children.
Purpose of the Study:
- To compare the effect of NPIs during the COVID-19 pandemic on vaccine-preventable IBIs versus invasive group A streptococcal (iGAS) infections in Swiss children.
- To analyze the distinct epidemiological dynamics of different bacterial pathogens in response to public health measures.
Main Methods:
- Nationwide, population-based, time-series analysis.
- Utilized data on IBIs in children across Switzerland.
- Compared incidence trends of specific bacterial pathogens before and during the COVID-19 pandemic.
Main Results:
- Vaccine-preventable IBIs demonstrated resilience to NPIs implemented during the COVID-19 pandemic.
- Invasive group A streptococcal infections showed a more pronounced response to the NPIs compared to vaccine-preventable IBIs.
- Epidemiological patterns of bacterial pathogens varied significantly in their susceptibility to public health interventions.
Conclusions:
- The study underscores that different bacterial pathogens exhibit unique responses to nonpharmaceutical interventions.
- Findings suggest that the impact of public health measures on pediatric bacterial infections is pathogen-specific.
- Further research into pathogen-specific dynamics is crucial for effective public health strategies against bacterial infections.
Abstract:
This nationwide, population-based, time-series analysis of invasive bacterial infections (IBIs) in Swiss children shows that vaccine-preventable IBIs were less affected by nonpharmaceutical interventions during the coronavirus disease 2019 (COVID-19) pandemic compared with invasive group A streptococcal infections. These findings emphasize the distinct epidemiological dynamics of bacterial pathogens in response to public health measures.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Urinary Tract Infection II: Pathophysiology
Pharmacokinetics in Pediatric Patients: Drug Distribution
Infection
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...

